FINWIRES · TerminalLIVE
FINWIRES

Chemtrade Logistics Downgraded To Market Perform At Raymond James

-- Chemtrade Logistics Income Fund (CHE-UN.TO) was downgraded to Market Perform from Strong Buy at Raymond James, Tuesday.

Analyst Steve Hansen lowered his price target on shares of the Canadian industrial chemicals and services company to $15 from $21.

"Last night we attended a District of North Vancouver (DNV) council meeting where we expected to observe the second and third readings of Rezoning Bylaw 8778, key steps toward advancing the rezoning and lease extension (to Dec-31-44) of Chemtrade's Electrochem (EC) facility," Hansen said in a note to clients.

"...Advancing this bylaw has long been viewed as the critical gating item to securing a long-term lease and mitigating operational constraints beginning Jun-30-30 that would otherwise force the plant shutdown," the analyst said.

"Instead, we observed a council that ignored the risk assessments solicited, dismissed senior government support (Federal/Provincial), sided with NIMBYISM, and ultimately suspended further readings of the bylaw (vote: 4-3) - thus squashing any near-term visibility on an extension," Hansen said.

"While an alternative path may still emerge, including higher-level government involvement/pressure, we struggle to assign a timeline/probability to such an outcome."

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605